Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Lidocaine 5% Medicated Plaster in Localized Chronic Post-operative Neuropathic Pain
The purpose of this trial is to investigate the efficacy and safety of lidocaine 5% medicated plaster in localized chronic post-operative neuropathic pain in comparison to placebo plaster.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
AUT004
Klagenfurt, Austria
AUT005
Senftenberg, Austria
AUT001
Vienna, Austria
AUT006
Vienna, Austria
AUT002
Vienna, Austria
AUT003
Vienna, Austria
BEL001
Gozée, Belgium
BEL006
Halen, Belgium
BEL004
Ham, Belgium
BEL007
Lanaken, Belgium
Start Date
October 1, 2012
Primary Completion Date
June 1, 2016
Completion Date
June 1, 2016
Last Updated
July 6, 2016
444
ACTUAL participants
Lidocaine 5% medicated plaster
DRUG
Placebo plaster
DRUG
Lead Sponsor
Grünenthal GmbH
NCT06346132
NCT07351968
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions